PepGen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PepGen and other ETFs, options, and stocks.About PEPG
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.
CEOJames Gregg McArthur
CEOJames Gregg McArthur
Employees81
Employees81
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2018
Founded2018
Employees81
Employees81
PEPG Key Statistics
Market cap387.05M
Market cap387.05M
Price-Earnings ratio-1.99
Price-Earnings ratio-1.99
Dividend yield—
Dividend yield—
Average volume749.50K
Average volume749.50K
High today—
High today—
Low today—
Low today—
Open price$5.43
Open price$5.43
Volume0.00
Volume0.00
52 Week high$7.80
52 Week high$7.80
52 Week low$0.8801
52 Week low$0.8801
Stock Snapshot
PepGen(PEPG) stock is priced at $5.63, giving the company a market capitalization of 387.05M. It carries a P/E multiple of -1.99.
On 2026-01-23, PepGen(PEPG) shares started trading at $5.43, with intraday highs of — and lows of —.
Trading volume for PepGen(PEPG) stock has reached 0, versus its average volume of 749.5K.
Over the past 52 weeks, PepGen(PEPG) stock has traded between a high of $7.80 and a low of $0.88.
Over the past 52 weeks, PepGen(PEPG) stock has traded between a high of $7.80 and a low of $0.88.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
0%
Sell
16.7%
People also own
Based on the portfolios of people who own PEPG. This list is generated using Robinhood data, and it’s not a recommendation.